| Financial Year |
March 31 2023 |
| Monetary Funds |
392,129,723.29 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
164,553,258.29 |
| Accounts Receivable |
2,170,047,896.99 |
| Advances to Suppliers |
149,827,889.24 |
| Other Receivables |
46,732,482.69 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
488,785,372.93 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
2,000,000.00 |
| Other Current Assets |
56,422,081.55 |
| Total Current Assets |
3,511,604,101.24 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
88,404,046.73 |
| Fixed Assetes |
9,016,325,339.16 |
| Under-construction Projects |
181,831,204.18 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
370,315,441.64 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
26,777,682.33 |
| Deferred Income Tax Assets |
129,709,428.93 |
| Other Non-Current Assets |
12,341,299.83 |
| Sub-Total of Non-Current Assets |
9,872,310,448.56 |
| Total Assets |
13,383,914,549.80 |
| Short-Term Loans |
1,405,200,099.68 |
| Trading Financial liabilities |
-- |
| Notes Payable |
237,850,372.00 |
| Accounts Payable |
385,909,306.87 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
19,388,636.73 |
| Taxes Payable |
26,047,927.21 |
| Interest Payable |
-- |
| Dividend Payable |
12,561,939.25 |
| Other payables |
318,555,276.23 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
557,190,010.72 |
| Other Current Liabilities |
87,319,333.80 |
| Sub-Total of Current Liabilities |
3,066,037,022.57 |
| Long-term Loans |
5,104,301,022.11 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
43,622,177.91 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
540,414.34 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,466,525,172.71 |
| Total Liabilities |
8,532,562,195.28 |
| Paid-In Capital(Or Share Stock) |
1,080,551,669.00 |
| Capital Surplus |
1,581,486,558.62 |
| Surplus Reserve |
895,979,366.05 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
954,823,539.77 |
| Minority Stockholder's Interest |
338,628,285.54 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,512,724,068.98 |
| Owner's Equity（Stockholder's Equity） |
4,851,352,354.52 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
13,383,914,549.80 |
